Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Supplier Deviation Management

Posted on By

SOP for Supplier Deviation Management

Supplier Deviation Management – Standard Operating Procedure

1) Purpose

To establish guidelines for managing deviations related to materials, components, or services supplied by external suppliers to ensure product quality, safety, and compliance within the pharmaceutical manufacturing department.

2) Scope

This SOP applies to all supplier-related deviations identified during receipt, inspection, testing, or use of materials, components, or services in pharmaceutical manufacturing.

3) Responsibilities

Quality Assurance Team: Responsible for investigating and managing supplier deviations.
Procurement Team: Responsible for communicating with suppliers and implementing corrective actions.

4) Procedure

4.1) Deviation Identification:
4.1.1) Identify and document deviations related to supplier materials, components, or services.
4.1.2) Classify deviations based on severity, impact on product quality, and regulatory implications.

See also  SOP for Minimum and Maximum Stock Levels

4.2) Supplier Notification:
4.2.1) Notify the supplier promptly upon identification of a deviation.
4.2.2) Provide detailed information about the deviation and request a supplier investigation report.

4.3) Supplier Investigation:
4.3.1) Review the supplier investigation report to understand root causes and corrective actions proposed.
4.3.2) Assess the adequacy of the supplier’s investigation and proposed corrective actions.

4.4) Risk Assessment:
4.4.1) Conduct a risk assessment to evaluate the impact of the supplier deviation on

product quality and patient safety.
4.4.2) Determine if the affected materials or components can be used, reworked, or need to be quarantined or rejected.

4.5) Corrective and Preventive Actions (CAPA):
4.5.1) Implement corrective actions to address immediate concerns and prevent recurrence.
4.5.2) Communicate CAPA requirements to the supplier and verify implementation effectiveness.

See also  SOP for IT Systems Used in Procurement

4.6) Documentation and Reporting:
4.6.1) Document all supplier deviation investigations, decisions, and actions taken.
4.6.2) Report significant deviations to management and regulatory authorities as required.

5) Abbreviations, if any

CAPA – Corrective and Preventive Actions

6) Documents, if any

  • Supplier Deviation Report Forms
  • Supplier Investigation Reports
  • Risk Assessment Templates
  • Communication Logs with Suppliers

7) Reference, if any

Regulatory Guidelines: FDA CFR Part 211.84, ICH Q10
Industry Standards: ISO 13485:2016

8) SOP Version

Version 1.0

Purchase Departments Tags:Contract negotiation SOP, Emergency purchase procedure SOP, Goods receiving process SOP, Handling expired materials SOP, Inventory management SOP, Laboratory supplies procurement SOP, Manufacturing equipment procurement SOP, Material inspection SOP, Material specification SOP, Minimum stock level SOP, Order confirmation SOP, Packaging material procurement SOP, Pharmaceutical purchase SOP, Purchase return process SOP, Raw material procurement SOP, SOP for purchase order creation, SOP for purchase requisition, SOP for supplier qualification, SOP for vendor audit, Stock replenishment planning SOP, Supplier corrective action SOP, Supplier non-conformance SOP, Supplier performance monitoring SOP, Vendor communication protocol SOP, Vendor selection criteria SOP

Post navigation

Previous Post: SOP for Leak Testing of Sealed Containers
Next Post: Injectables: SOP for Handling of Complaints

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version